Rolls-Royce to sell stake in RTM322 helicopter programme
FTSE 100-listed defence aerospace and energy giant Rolls-Royce has reached an agreement to sell its shareholding and interest in the RTM322 helicopter engine programme to Turbomeca, a Safran company.
FTSE 100-listed defence aerospace and energy giant Rolls-Royce has reached an agreement to sell its shareholding and interest in the RTM322 helicopter engine programme to Turbomeca, a Safran company.
Rolls-Royce said that its 50% interest in the engine programme would be progressively transferred to Turbomeca, which would then hold 100% of the RTM322 programme.
Rolls-Royce would receive a cash consideration of €293m for its shareholding and interest in the programme, the group added.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Under the terms of the agreement, Turbomeca will assume full responsibility for the design, production and support of the RTM322 engine, which powers the Apache, EH101 Merlin and NH90 helicopters.
The group said that the RRTM Adour engine programme and other helicopter engine programmes in the Rolls-Royce portfolio would be unaffected by the agreement.
The sale is expected to complete before year end, subject to closing conditions.
MF
Sign up to Money Morning
Our team, led by award winning editors, is dedicated to delivering you the top news, analysis, and guides to help you manage your money, grow your investments and build wealth.
-
Energy bills to rise by 1.2% in January 2025
Energy bills are set to rise 1.2% in the New Year when the latest energy price cap comes into play, Ofgem has confirmed
By Dan McEvoy Published
-
Should you invest in Trainline?
Ticket seller Trainline offers a useful service – and good prospects for investors
By Dr Matthew Partridge Published